Article content material
Loblaw Corporations Ltd. is investing $75 million in digital well being supplier Maple Company as the grocery store continues to broaden its footprint in healthcare.
The funding in Maple, the biggest digital care supplier in Canada, provides Loblaw a minority stake within the firm.
Loblaw and Maple already had a historical past collectively. The 2 partnered to make digital care obtainable at 160 Consumers Drug Marts in B.C. And after COVID-19 hit Canada in March, they offered digital care, together with screenings for the virus, to hundreds of Canadians.
Consumers Drug Mart president Jeff Leger stated the pandemic has proven that Canadians want alternate options to conventional well being care.
“The COVID-19 pandemic has confirmed that Canadians want new methods, significantly digital methods, to get entry to care,” stated Leger. “We all know that the way forward for healthcare is digitally enabled. We imagine that our retailer community and infrastructure, mixed with Maple’s know-how will help higher join Canadians to the healthcare assist they want, at any time when and wherever they’re.”
The funding into Maple is the newest in a collection of healthcare investments made by Loblaw over the previous decade, starting with its acquisition of Consumers Drug Mart in 2014. Two years later, it acquired QHR Corp., which was on the time a pacesetter within the digital medical information market, for $170 million.
• Electronic mail: | Twitter: VicF77
